Academia Sinica yesterday said that its researchers have developed an antibody testing method for COVID-19 and have made progress synthesizing remdesivir, a medicine that many believe could cure the infection.
The Centers for Disease Control on Tuesday sent serum samples to Academia Sinica of three people who had contact with Taiwan’s first COVID-19 fatality, as part of an effort to determine the source of that infection.
The three had tested negative for RNA viruses, but the centers hoped to discover if they had developed antibodies.
Photo courtesy of Academia Sinica
Test results showed that only one sample had antibodies for COVID-19 and SARS, Academia Sinica Institute of Biomedical Sciences research fellow Lin Yi-ling (林宜玲) said.
The sample was obtained from a Taiwanese businessperson who was not listed as a confirmed case, because their immune system beat the virus, she said.
Little is known about COVID-19, so it is still a mystery whether a person who has recovered from it can contract it again, she added.
The method is useful in tracing the transmission chain of a certain case, Institute of Plant and Microbial Biology Director Wu Shu-hsing (吳素幸) said, but added that testing for RNA viruses tells whether a person contracts COVID-19.
Using molecular biology and genetic engineering, Wu said that she pieced together plasmids — a kind of DNA for expressing antigens — in small templates to make up longer series of plasmids for producing the antigens used to test for COVID-19, SARS and Middle East respiratory syndrome antibodies.
Ordering massive plasmid series from overseas manufacturers takes two to three weeks, Lin said, praising Wu’s team for only needing a week.
After Institute of Biological Chemistry associate research fellow Ho Meng-chiao (何孟樵) purified the nucleocapsid protein of COVID-19 for making reagents, Lin used the western blot method to place the antigens in a serum sample for testing antibody reactions, she said.
Another team led by Institute of Chemistry associate research fellow Chein Rong-jie (陳榮傑) succeeded in synthesizing 100mg of remdesivir in two weeks.
Unable to obtain the raw materials in time, they used materials on hand and molecule synthesis, referencing public-domain literature, to make the drug, which on Thursday was 97 percent as pure as the original, Chein said.
Before the centers tasked them with the mission, Academia Sinica President James Liao (廖俊智) last month formed a task force to speed up the development of antigens, antibodies, drugs and vaccines for COVID-19.
The synthesized drug cannot be used without the consent of the US pharmaceutical firm that manufactures remdesivir, Liao said.
Nonetheless, the achievement showed that Academia Sinica is capable of drug synthesis and could facilitate mass production of the drug after a technology transfer has been completed, he added.
SAFETY RISK: The government is working to categorize countries based on their COVID-19 cases and prevention efforts, which would determine quarantine periods The government plans to rank countries based on their COVID-19 risks to determine how to treat tourists and other travelers from those nations once Taiwan reopens its borders, but it is still working out the categories, a top health official told lawmakers yesterday. “We would divide countries around the world into several categories. One category would comprise those countries with very few confirmed COVID-19 cases, such as New Zealand and Palau. Travelers from the countries in this category would only need to practice self-health management,” Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥) told a Legislative Yuan seminar hosted by
SECURITY CONCERNS: The Telecom Technology Center ran black-box tests for the Executive Yuan on devices and software from Chinese, US and South Korean firms Network devices from several Chinese manufacturers are insecure and allow personal information to be leaked, testing commissioned by the Executive Yuan has shown. A variety of devices and software, including apps, from Chinese, US and South Korean manufacturers that are used by government agencies at the central and local level were subjected to black-box testing — in which the functionality of an application is examined without knowing about its internal structure, an information-security official said yesterday on condition of anonymity. The Telecom Technology Center conducted the tests, which simulated cyberattacks, to determine their resilience to the attacks, the official said. The center
CASH BOOST: Foreign spouses with residency permits are also eligible for the coupons, which can be bought at post offices or linked to digital payment options Stimulus coupons for Taiwanese and foreign spouses with residency permits can be ordered starting on July 1 and can be used from July 15 to Dec. 31, the Executive Yuan said yesterday. Aimed at boosting domestic spending, the coupons worth NT$3,000 (US$100.04) are to cost NT$1,000. “For our consumers, this is a very good deal as they get three times as much value for their money,” Premier Su Tseng-chang (蘇貞昌) told a news conference in Taipei. While the coupons are to have a wide range of uses, including at department stores, restaurants, book stores, night markets, beauty and hair salons, hotels, and to
Beijing is to ease a ban on foreign airlines starting on Monday next week, changing course one day after the administration of US President Donald Trump demanded that China reopen to US airlines or face curbs on its own carriers flying passengers to the US. Foreign airlines excluded from an earlier pact would be able to operate one commercial passenger flight to China per week, the Chinese Civil Aviation Administration said. It did not name any countries or carriers, but the move opens up a chance for US airlines to return for the first time in four months. While the timing might